EDAP TMS SA to Attend H.C. Wainwright Investment Conference
EDAP TMS SA (Nasdaq: EDAP), a leading company in robotic energy-based therapies, is gearing up to participate in the H.C. Wainwright 26th Annual Global Investment Conference. This event presents an excellent opportunity for the company to connect with investors and highlight its groundbreaking technologies.
Details of the Conference Participation
Ryan Rhodes, the Chief Executive Officer of EDAP TMS, will take part in a fireside chat and hold one-on-one meetings with investors during this prestigious event, which runs from September 9 to September 11. These sessions will facilitate meaningful discussions about future opportunities and insights in the healthcare industry.
Scheduled Events
Ryan Rhodes is scheduled to speak on Tuesday, September 10, from 3:00 PM to 3:30 PM ET. Attendees can look forward to an engaging conversation that will cover the company’s strategic direction and innovations in therapeutic ultrasound technologies.
Location of the Conference
The conference will take place at the Lotte New York Palace Hotel, a well-known venue for significant financial events, making it an ideal setting for networking with potential investors.
Streaming Details
For those who cannot attend in person, EDAP TMS will offer a live webcast of the fireside chat, along with an archived version available later on the company's Investor Relations webpage. This ensures that interested parties can stay updated on the discussions and insights shared during the conference.
About EDAP TMS SA
EDAP TMS SA is recognized as a trailblazer in the global therapeutic ultrasound market. The company is committed to developing and manufacturing minimally invasive medical devices designed to treat various conditions using advanced ultrasound technology. Their innovative approach integrates state-of-the-art imaging and treatment methods, particularly through their Robotic High-Intensity Focused Ultrasound (HIFU) devices.
Technological Innovations
The launch of Focal One, a state-of-the-art robotic device, places EDAP TMS at the leading edge of prostate cancer treatment options. This technology offers comprehensive solutions that span diagnostics to focal treatment, enabling precise ablation of prostate tissue.
Product Portfolio
Alongside Focal One, the company also provides ExactVu™ Micro-Ultrasound, which enhances its ability to deliver targeted treatments. Additionally, EDAP manufactures the Sonolith® i-move lithotripter, a device specifically designed to treat urinary tract stones using extracorporeal shockwave lithotripsy (ESWL) technology.
Contact Information
For additional inquiries, interested individuals can contact EDAP's Investor Relations. Blandine Confort, who leads Investor Relations and Legal Affairs, is available at +33 4 72 15 31 50 or via email at bconfort@edap-tms.com. Furthermore, John Fraunces from LifeSci Advisors, LLC is also on hand to assist with investor-related questions, reachable at (917) 355-2395 or via email at jfraunces@lifesciadvisors.com.
Frequently Asked Questions
What is the H.C. Wainwright Global Investment Conference?
The H.C. Wainwright Global Investment Conference is an important event that gathers public and private companies to share insights and connect with investors.
Who will represent EDAP TMS SA at the conference?
Ryan Rhodes, the CEO of EDAP TMS SA, will be the representative for the company during the conference.
Where will the conference take place?
The conference will be held at the Lotte New York Palace Hotel in New York.
How can one access the webcast of the conference?
The live and archived webcasts will be available through the Investors section of EDAP TMS's website.
What technologies does EDAP TMS SA focus on?
EDAP TMS SA specializes in robotic energy-based therapies and minimally invasive medical devices that utilize ultrasound technology for a variety of treatments.
